BACKGROUND: With the establishment of laser photocoagulation as a standard treatment modality for prethreshold retinopathy of prematurity (ROP), a dramatic reduction of cases with ROP blindness and severe visual impairment have been reported. In the same time, high refractive errors, a common complication in ROP cases and especially in ROP treated infants, have become the main cause of visual and often severe visual impairment. AIM: The purpose of our study was to analyse the long-term refractive status in children at 3.5 years after laser-treatment for type 1 prethreshold ROP. PATIENTS AND METHODS: A retrospective, one centre study of refractive status of 18 children with laser-treated type 1 prethreshold ROP was conducted. The refraction ...
Aims: To evaluate retreatment rates, visual and anatomical outcomes at 1-year postnatal age in infan...
Retinopathy of prematurity (ROP) is a leading cause of blindness in children and one of the most imp...
Aims: To determine the ophthalmological outcome at 6.5 years of age in children treated for retinopa...
Background: Infants treated for retinopathy of prematurity (ROP) could develop visually significant ...
Purpose: In this case–control study, we measured visual acuity, objective refraction, ocular biometr...
AbstractPurposeTo assess the long term visual outcomes and refractive status of patients who underwe...
Background: Infants treated for retinopathy of prematurity (ROP) can develop visually signific...
To assess the long-term refractive and biometric outcomes of diode laser-treated eyes in threshold r...
To assess the long term functional and structural outcomes of premature babies who received diode la...
Phuoc Huu Nguyen,1,2 Caroline Catt,2 Tinh Xuan Nguyen,3 Van Trong Pham4,51Department of Ophthalmolog...
PURPOSE: To compare long-term refractive outcomes associated with intravitreal anti-vascular endothe...
ROP is a vaso-proliferative disorder of premature /preterm infants with gestational age less than 3...
Background/Aim. Retinopathy of prematurity (ROP) is a vasoproliferative retinopathy which affects th...
This study evaluated the extent to which refractive morbidity is correlated to preterm birth or reti...
AbstractThis study evaluated the extent to which refractive morbidity is correlated to preterm birth...
Aims: To evaluate retreatment rates, visual and anatomical outcomes at 1-year postnatal age in infan...
Retinopathy of prematurity (ROP) is a leading cause of blindness in children and one of the most imp...
Aims: To determine the ophthalmological outcome at 6.5 years of age in children treated for retinopa...
Background: Infants treated for retinopathy of prematurity (ROP) could develop visually significant ...
Purpose: In this case–control study, we measured visual acuity, objective refraction, ocular biometr...
AbstractPurposeTo assess the long term visual outcomes and refractive status of patients who underwe...
Background: Infants treated for retinopathy of prematurity (ROP) can develop visually signific...
To assess the long-term refractive and biometric outcomes of diode laser-treated eyes in threshold r...
To assess the long term functional and structural outcomes of premature babies who received diode la...
Phuoc Huu Nguyen,1,2 Caroline Catt,2 Tinh Xuan Nguyen,3 Van Trong Pham4,51Department of Ophthalmolog...
PURPOSE: To compare long-term refractive outcomes associated with intravitreal anti-vascular endothe...
ROP is a vaso-proliferative disorder of premature /preterm infants with gestational age less than 3...
Background/Aim. Retinopathy of prematurity (ROP) is a vasoproliferative retinopathy which affects th...
This study evaluated the extent to which refractive morbidity is correlated to preterm birth or reti...
AbstractThis study evaluated the extent to which refractive morbidity is correlated to preterm birth...
Aims: To evaluate retreatment rates, visual and anatomical outcomes at 1-year postnatal age in infan...
Retinopathy of prematurity (ROP) is a leading cause of blindness in children and one of the most imp...
Aims: To determine the ophthalmological outcome at 6.5 years of age in children treated for retinopa...